GlassScriptPhysician profile
Ingrid M Stines
NPI 1821182023
$2,827.09
in general payments reported to CMS, 2019-2025
20 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $13.25 · 2021: $67.19 · 2022: $79.98 · 2023: $19.44 · 2024: $539 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337 · Travel and Lodging: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.00 |
| Travel and Lodging | $990.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,681.06 | 2023-2025 | |
| Convatec INC. | $250.46 | 2022-2024 | |
| Medtronic, INC. | $189.09 | 2022-2025 | In.Pact Admiral, Intellis Adaptivestim, Activos 10 Bone Cement |
| Kerecis Limited | $114.37 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Wright Medical Technology, INC. | $113.47 | 2019 | |
| Paragon 28, INC. | $69.86 | 2019-2025 | Bun-Yo-Matic |
| Melinta Therapeutics, LLC | $55.40 | 2019 | |
| Mimedx Group, INC. | $52.89 | 2025 | |
| Orthofix Medical, INC. | $52.12 | 2019-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $50.00 | 2019 | |
| Grt US Holding, INC. | $39.27 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $35.78 | 2021-2022 | |
| Smith+Nephew, INC. | $23.01 | 2019 | |
| Heron Therapeutics, INC. | $21.82 | 2021 | |
| Cashflow Solutions, LLC | $19.34 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $14.75 | 2019 | |
| Abbvie INC. | $14.35 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2022 | |
| Arthrosurface Incorporated | $11.31 | 2019 | |
| Cardiovascular Systems INC. | $6.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Stines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.